发明名称 THERAPEUTIC USE OF FACTOR XI
摘要 <p>The present invention provides methods and compositions for treating bleeding episodes. The methods are carried out by administering to a patient in need thereof a preparation comprising a factor XI polypeptide, in an amount effective for such treatment. The methods of the invention result in one or more of: reduced clotting time; enhancement of hemostasis; increase in clot lysis time; increase in clot strength; and/or increase in overall clot quality (OCQ) in said patient.</p>
申请公布号 CA2540986(A1) 申请公布日期 2005.06.02
申请号 CA20042540986 申请日期 2004.11.22
申请人 NOVO NORDISK HEALTH CARE AG 发明人 JENSEN, SIMON BJERREGAARD;VIUFF, DORTHE;OESTERGAARD, SOEREN;HANSEN, JENS JACOB;ROEJKJAER, RASMUS
分类号 A61K38/36;A61K38/10;A61K38/48;A61K38/55;A61P7/00;A61P7/04 主分类号 A61K38/36
代理机构 代理人
主权项
地址